Frontlight ResearchEarly access
Trial site
CHU de Quebec-Universite Laval-Hotel Dieu de Quebec
- 2running trials
- 5closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Stroke2 trials
- Atrial fibrillation1 trial
- Chronic kidney disease1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Heart failure1 trial
- Kidney cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 36 trials
- Phase 21 trial
- Status
- Completed4 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Incyte Corporation2 trials
- Eisai Inc.1 trial
- Eli Lilly and Company1 trial
- Hoffmann-La Roche1 trial
- Montreal Heart Institute1 trial
- and 1 more
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease1 recruiting
- Heart failure1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Completed
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
Completed
Completed
Terminated
Site data: ClinicalTrials.govUpdated 12 Nov 2026